Sees FY25 revenue $822M-$824M, consensus $821.8M. These preliminary results will be included in a presentation that will be made available through a live webcast in the investor relations section of the Myriad Genetics (MYGN) on Wednesday, January 14, 2026 at 5:15 pm PT in connection with the company’s presentation at the 44th Annual J.P. Morgan Healthcare Conference.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYGN: